FGFR Inhibitor Resistance in cholangiocarcinoma: Current understanding and future directions

Expert Opin Pharmacother. 2023 Sep 14. doi: 10.1080/14656566.2023.2259802. Online ahead of print.NO ABSTRACTPMID:37710362 | DOI:10.1080/14656566.2023.2259802

Source: Expert Opinion on Pharmacotherapy - September 15, 2023 Category: Drugs & Pharmacology Authors: Daniel Neureiter Peter Ellinghaus Matthias Ocker Source Type: research